We are live on ! Find out more
SPWM

Straight Path Wealth Management Portfolio holdings

AUM $428M
1-Year Est. Return 26.3%
This Fund
S&P 500
This Quarter Est. Return
-1.87%
1 Year Est. Return
+26.3%
3 Year Est. Return
+70.6%
5 Year Est. Return
10 Year Est. Return
AUM
$374M
AUM Growth
+$3.47M
Cap. Flow
+$14.6M
Cap. Flow %
3.9%
Top 10 Hldgs %
69.2%
Holding
137
New
8
Increased
70
Reduced
24
Closed
8

Top Sells

Rank Stock Value
1
TEVA icon
Teva Pharmaceuticals
TEVA
+$1.56M
2
RKLB icon
Rocket Lab Corp
RKLB
+$1.27M
3
PLTR icon
Palantir
PLTR
+$639K
4
RBRK icon
Rubrik
RBRK
+$311K
5
IONQ icon
IonQ
IONQ
+$288K

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 11.76%
2 Technology 2.12%
3 Healthcare 0.84%
4 Financials 0.43%
5 Communication Services 0.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DDFJ
126
Innovator Equity Dual Directional 15 Buffer ETF - January
DDFJ
$73.9M
$194K 0.05%
+10,328
New +$196K
EC icon
127
Ecopetrol
EC
$32.5B
$150K 0.04%
10,000
LXRX icon
128
Lexicon Pharmaceuticals
LXRX
$1.04B
$97.8K 0.03%
62,666
RR icon
129
Richtech Robotics
RR
$322M
$29.7K 0.01%
14,200
+3,000
+27% +$9.22K
IONQ icon
130
IonQ
IONQ
$12.6B
-6,410
Closed -$288K
IVOL icon
131
Quadratic Interest Rate Volatility and Inflation Hedge ETF
IVOL
$271M
-10,579
Closed -$203K
IVW icon
132
iShares S&P 500 Growth ETF
IVW
$71.9B
-1,734
Closed -$214K
RBLX icon
133
Roblox
RBLX
$35.4B
-2,500
Closed -$203K
RKLB icon
134
Rocket Lab Corp
RKLB
$39.9B
-18,200
Closed -$1.27M
SCHW
135
Charles Schwab
SCHW
$184B
-2,021
Closed -$202K
TEVA icon
136
Teva Pharmaceuticals
TEVA
$36.9B
-50,000
Closed -$1.56M
RBRK icon
137
Rubrik
RBRK
$14.7B
-4,070
Closed -$311K

Similar funds

Straight Path Wealth Management's Q1 2026 Portfolio in Review

As of Q1 2026, Straight Path Wealth Management held 137 positions worth $374M, up 0.94% from $371M the previous quarter. Its ten largest holdings account for 69% of the portfolio.

Straight Path Wealth Management deployed $14.6M of net new capital in Q1 2026, opening 8 new positions and adding to 70 existing holdings. Its largest new stake was Coherent: 3,150 shares worth $750K.

By sector, the portfolio is most concentrated in Consumer Discretionary at 12% of assets, down from 14% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Palantir, an estimated $639K trimmed.

  • Straight Path Wealth Management's largest Q1 2026 buy was Coherent: 3,150 shares worth $750K.
  • Straight Path Wealth Management added most to Dimensional US Core Equity 2 ETF in Q1 2026, an estimated $4.77M increase.
  • Straight Path Wealth Management's biggest Q1 2026 reduction was Palantir, cutting an estimated $639K.
  • Straight Path Wealth Management fully exited Teva Pharmaceuticals in Q1 2026, selling an estimated $1.56M.
  • Straight Path Wealth Management's ten largest holdings make up 69% of its $374M portfolio in Q1 2026.
  • Straight Path Wealth Management opened 8 new positions and closed 8 in Q1 2026.
  • Straight Path Wealth Management's portfolio value rose 0.94% quarter-over-quarter to $374M.

Based on Straight Path Wealth Management's 13F filing for Q1 2026, filed 23 Apr 2026.